Convalescent plasma therapy in the treatment of COVID-19: Practical considerations: Correspondence.
作者信息
Islam Amin, Rafiq Shafquat, Karim Sabina, Laher Ismail, Rashid Harunor
机构信息
Mid and South Essex University Hospitals Group NHS Trust, Westcliffe on Sea, Prittlewell Chase, SS0 0RY, UK; Department of Haematology and Oncology, Faculty of Medicine and Dentistry, Queen Mary University, London, E1 4NS, UK; Anglia Ruskin Medical School, Bishop Hall Ln, Chelmsford, CM1 1SQ, UK.
Department of Gastroenterology, East Kent University Hospitals NHS Trust, Kennington Rd, Willesborough, Ashford, TN24 0LZ, UK.
出版信息
Int J Surg. 2020 Jul;79:204-205. doi: 10.1016/j.ijsu.2020.05.079. Epub 2020 Jun 2.
Abstract
摘要
相似文献
1
Convalescent plasma therapy in the treatment of COVID-19: Practical considerations: Correspondence.恢复期血浆疗法治疗COVID-19：实际考量：通信
Int J Surg. 2020 Jul;79:204-205. doi: 10.1016/j.ijsu.2020.05.079. Epub 2020 Jun 2.
2
Convalescent plasma therapy in the treatment of COVID-19: Some considerations: Correspondence.恢复期血浆疗法治疗新型冠状病毒肺炎：一些思考：通信
Int J Surg. 2020 Aug;80:26. doi: 10.1016/j.ijsu.2020.06.029. Epub 2020 Jun 22.
3
Convalescent plasma to treat coronavirus disease 2019 (COVID-19): considerations for clinical trial design.恢复期血浆治疗 2019 冠状病毒病（COVID-19）：临床试验设计的考虑因素。
Transfusion. 2020 Jun;60(6):1123-1127. doi: 10.1111/trf.15843. Epub 2020 May 12.
4
A 63-Year-Old Woman with SARS-CoV-2 Infection, Who Developed Severe COVID-19 Pneumonia and Was Supported with Convalescent Plasma Therapy.一名63岁感染严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的女性，她发展为重症冠状病毒病2019（COVID-19）肺炎并接受了恢复期血浆治疗。
Am J Case Rep. 2020 Sep 29;21:e927662. doi: 10.12659/AJCR.927662.
5
Convalescent plasma therapy and remdesivir duo successfully salvaged an early liver transplant recipient with severe COVID-19 pneumonia.恢复期血浆疗法联合瑞德西韦成功挽救了一名患有重症COVID-19肺炎的早期肝移植受者。
Ann Hepatobiliary Pancreat Surg. 2020 Nov 30;24(4):526-532. doi: 10.14701/ahbps.2020.24.4.526.
6
Treatment of COVID-19: Perspective on Convalescent Plasma Transfusion.新型冠状病毒肺炎的治疗：恢复期血浆输注的前景
Front Med (Lausanne). 2020 Jul 28;7:435. doi: 10.3389/fmed.2020.00435. eCollection 2020.
7
Low Dose Radiation Therapy and Convalescent Plasma: How a Hybrid Method May Maximize Benefits for COVID-19 Patients.低剂量放射疗法与恢复期血浆：一种混合方法如何使新冠肺炎患者的益处最大化。
J Biomed Phys Eng. 2020 Aug 1;10(4):387-394. doi: 10.31661/jbpe.v0i0.2006-1125. eCollection 2020 Aug.
8
[Effect of convalescent plasma and immunoglobulin on patients with severe acute respiratory syndrome: a systematic review].[康复期血浆及免疫球蛋白对重症急性呼吸综合征患者的影响：一项系统评价]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020 Apr;32(4):435-438. doi: 10.3760/cma.j.cn121430-20200326-00240.
9
Convalescent plasma: A possible treatment of COVID-19 in India.康复血浆：印度治疗新冠肺炎的一种可能方法。
Med J Armed Forces India. 2020 Apr;76(2):236-237. doi: 10.1016/j.mjafi.2020.04.006. Epub 2020 Apr 15.
引用本文的文献
1
Progress in COVID research and developments during pandemic.疫情期间新冠病毒研究与进展
View (Beijing). 2022 Jul 20:20210020. doi: 10.1002/VIW.20210020.
2
Perplexing issues for convalescent immune plasma therapy in COVID-19.新冠康复期免疫血浆疗法面临的棘手问题。
North Clin Istanb. 2021 Nov 15;8(6):634-643. doi: 10.14744/nci.2021.73604. eCollection 2021.
3
Convalescent plasma bank facility location-allocation problem for COVID-19.新冠肺炎康复者血浆库设施选址-分配问题
Transp Res E Logist Transp Rev. 2021 Dec;156:102517. doi: 10.1016/j.tre.2021.102517. Epub 2021 Oct 28.
4
Confidentiality challenges surrounding plasma therapy during the COVID-19 pandemic: a case discussion in Iran.新冠疫情期间血浆疗法的保密挑战：伊朗的一个案例讨论
J Med Ethics Hist Med. 2020 Dec 21;13:27. doi: 10.18502/jmehm.v13i27.5044. eCollection 2020.
5
The predictors of high titer of -SARS-CoV-2 antibody of convalescent plasma donors.康复期血浆捐献者中新冠病毒抗体高滴度的预测因素。
Clin Epidemiol Glob Health. 2021 Jul-Sep;11:100763. doi: 10.1016/j.cegh.2021.100763. Epub 2021 May 10.
6
Convalescent Plasma for the Prevention and Treatment of COVID-19: A Systematic Review and Quantitative Analysis.恢复期血浆用于 COVID-19 的预防和治疗：系统评价和定量分析。
JMIR Public Health Surveill. 2021 Apr 7;7(4):e25500. doi: 10.2196/25500.
7
Double-Barreled CRISPR Technology as a Novel Treatment Strategy For COVID-19.双管CRISPR技术作为治疗新冠肺炎的一种新策略
ACS Pharmacol Transl Sci. 2020 Aug 27;3(5):790-800. doi: 10.1021/acsptsci.0c00071. eCollection 2020 Oct 9.
8
Convalescent plasma therapy: a promising coronavirus disease 2019 treatment strategy.恢复期血浆疗法：一种有前景的 2019 冠状病毒病治疗策略。
Open Biol. 2020 Sep;10(9):200174. doi: 10.1098/rsob.200174. Epub 2020 Sep 9.
9
Convalescent plasma therapy in the treatment of COVID-19: Some considerations: Correspondence.恢复期血浆疗法治疗新型冠状病毒肺炎：一些思考：通信
Int J Surg. 2020 Aug;80:26. doi: 10.1016/j.ijsu.2020.06.029. Epub 2020 Jun 22.
本文引用的文献
1
Effect of Convalescent Plasma Therapy on Viral Shedding and Survival in Patients With Coronavirus Disease 2019.新冠肺炎患者恢复期血浆疗法对病毒脱落和生存的影响。
J Infect Dis. 2020 Jun 16;222(1):38-43. doi: 10.1093/infdis/jiaa228.
2
Treatment with convalescent plasma for COVID-19 patients in Wuhan, China.中国武汉 COVID-19 患者恢复期血浆治疗。
J Med Virol. 2020 Oct;92(10):1890-1901. doi: 10.1002/jmv.25882. Epub 2020 Jun 29.
3
Use of Convalescent Plasma Therapy in Two COVID-19 Patients with Acute Respiratory Distress Syndrome in Korea.韩国两名急性呼吸窘迫综合征 COVID-19 患者使用恢复期血浆疗法。
J Korean Med Sci. 2020 Apr 13;35(14):e149. doi: 10.3346/jkms.2020.35.e149.
4
Effectiveness of convalescent plasma therapy in severe COVID-19 patients.恢复期血浆疗法治疗重症 COVID-19 患者的疗效。
Proc Natl Acad Sci U S A. 2020 Apr 28;117(17):9490-9496. doi: 10.1073/pnas.2004168117. Epub 2020 Apr 6.
5
Treatment With Convalescent Plasma for Critically Ill Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection.恢复期血浆治疗严重急性呼吸综合征冠状病毒 2 感染的危重症患者。
Chest. 2020 Jul;158(1):e9-e13. doi: 10.1016/j.chest.2020.03.039. Epub 2020 Mar 31.
6
Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma.5 例危重症 COVID-19 患者接受恢复期血浆治疗。
JAMA. 2020 Apr 28;323(16):1582-1589. doi: 10.1001/jama.2020.4783.
Zotero 插件